201 related articles for article (PubMed ID: 35874786)
1. Increased Expression of Multiple Co-Inhibitory Molecules on Malaria-Induced CD8
Brandi J; Riehn M; Hadjilaou A; Jacobs T
Front Immunol; 2022; 13():878320. PubMed ID: 35874786
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
3. T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function in mice.
Brandi J; Lehmann C; Kaminski LC; Schulze Zur Wiesch J; Addo M; Ramharter M; Mackroth M; Jacobs T; Riehn M
Eur J Immunol; 2022 Feb; 52(2):312-327. PubMed ID: 34752634
[TBL] [Abstract][Full Text] [Related]
4. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Mollavelioglu B; Cetin Aktas E; Cabioglu N; Abbasov A; Onder S; Emiroglu S; Tükenmez M; Muslumanoglu M; Igci A; Deniz G; Ozmen V
World J Surg Oncol; 2022 Oct; 20(1):349. PubMed ID: 36271406
[TBL] [Abstract][Full Text] [Related]
5. Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.
Zhang Y; Jiang N; Zhang T; Chen R; Feng Y; Sang X; Yang N; Chen Q
Parasit Vectors; 2019 Nov; 12(1):534. PubMed ID: 31711531
[TBL] [Abstract][Full Text] [Related]
6. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.
Anderson AC; Joller N; Kuchroo VK
Immunity; 2016 May; 44(5):989-1004. PubMed ID: 27192565
[TBL] [Abstract][Full Text] [Related]
7. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
[TBL] [Abstract][Full Text] [Related]
8. [The expression and correlation analysis of TOX and inhibitory receptors on peripheral blood CD8
Yan L; Yang JR; Wang HQ; Shao ZH
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2095-2099. PubMed ID: 37455127
[No Abstract] [Full Text] [Related]
9. Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
Lavon I; Heli C; Brill L; Charbit H; Vaknin-Dembinsky A
Front Immunol; 2019; 10():835. PubMed ID: 31134049
[No Abstract] [Full Text] [Related]
10. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.
Hafalla JC; Claser C; Couper KN; Grau GE; Renia L; de Souza JB; Riley EM
PLoS Pathog; 2012 Feb; 8(2):e1002504. PubMed ID: 22319445
[TBL] [Abstract][Full Text] [Related]
11. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
[TBL] [Abstract][Full Text] [Related]
12. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.
Nakamoto N; Cho H; Shaked A; Olthoff K; Valiga ME; Kaminski M; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
PLoS Pathog; 2009 Feb; 5(2):e1000313. PubMed ID: 19247441
[TBL] [Abstract][Full Text] [Related]
13. CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
Fourcade J; Sun Z; Pagliano O; Guillaume P; Luescher IF; Sander C; Kirkwood JM; Olive D; Kuchroo V; Zarour HM
Cancer Res; 2012 Feb; 72(4):887-96. PubMed ID: 22205715
[TBL] [Abstract][Full Text] [Related]
14. miR-149-3p reverses CD8
Zhang M; Gao D; Shi Y; Wang Y; Joshi R; Yu Q; Liu D; Alotaibi F; Zhang Y; Wang H; Li Q; Zhang ZX; Koropatnick J; Min W
Open Biol; 2019 Oct; 9(10):190061. PubMed ID: 31594465
[TBL] [Abstract][Full Text] [Related]
15. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
[TBL] [Abstract][Full Text] [Related]
17. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
[TBL] [Abstract][Full Text] [Related]
18. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
Richter K; Agnellini P; Oxenius A
Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
[TBL] [Abstract][Full Text] [Related]
19. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
